Emerging evidence has implicated miR-210 in evoking Akt activation and thereby inhibiting apoptosis, fostering cellular proliferation and metastasis, albeit in clinical tumor specimens and primary cancer cells from patient-derived xenografts [127,128]. The gene discussed is AKT1; the disease is cancer.